Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1994 1
1996 1
1997 2
1999 1
2000 1
2001 1
2002 2
2004 2
2005 1
2006 3
2007 2
2008 4
2009 1
2010 4
2011 3
2012 5
2013 6
2014 5
2015 10
2016 5
2017 6
2018 4
2019 5
2020 8
2021 4
2022 5
2023 7
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Among authors: figueroa ms. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Reply.
Holz FG, Figueroa MS, Bandello F, Yang Y, Ohji M, Dai H, Wykrota H, Sharma S, Dunger-Baldauf C, Lacey S, Macfadden W, Mitchell P; all the LUMINOUS study investigators. Holz FG, et al. Among authors: figueroa ms. Retina. 2020 Sep;40(9):e51-e53. doi: 10.1097/IAE.0000000000002909. Retina. 2020. PMID: 32842092 No abstract available.
Reply.
Figueroa MS, Govetto A, Contreras I, Ruiz-Moreno JM, del Valle FG, Plascencia RN, Medina JL. Figueroa MS, et al. Retina. 2016 Jan;36(1):e4-5. doi: 10.1097/IAE.0000000000000915. Retina. 2016. PMID: 26702607 No abstract available.
Reply.
Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Govetto A, et al. Among authors: figueroa ms. Am J Ophthalmol. 2017 Jul;179:207. doi: 10.1016/j.ajo.2017.04.017. Epub 2017 May 4. Am J Ophthalmol. 2017. PMID: 28478922 No abstract available.
Reply.
Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Govetto A, et al. Among authors: figueroa ms. Am J Ophthalmol. 2017 May;177:227-229. doi: 10.1016/j.ajo.2017.02.005. Epub 2017 Mar 3. Am J Ophthalmol. 2017. PMID: 28262181 No abstract available.
Optical coherence tomography-based consensus definition for lamellar macular hole.
Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS, Sebag J, Gaudric A, Staurenghi G, Haritoglou C, Kadonosono K, Thompson JT, Chang S, Bottoni F, Tadayoni R. Hubschman JP, et al. Among authors: figueroa ms. Br J Ophthalmol. 2020 Dec;104(12):1741-1747. doi: 10.1136/bjophthalmol-2019-315432. Epub 2020 Feb 27. Br J Ophthalmol. 2020. PMID: 32107208 Review.
3D vitrectomy. Is it really useful?
Figueroa MS. Figueroa MS. Arch Soc Esp Oftalmol. 2017 Jun;92(6):249-250. doi: 10.1016/j.oftal.2017.02.001. Epub 2017 Mar 17. Arch Soc Esp Oftalmol. 2017. PMID: 28318832 English, Spanish. No abstract available.
Guidance on brolucizumab management recommendations.
Fonollosa A, Gallego-Pinazo R, Sararols L, Adán A, López-Gálvez M, Figueroa MS. Fonollosa A, et al. Among authors: figueroa ms. Arch Soc Esp Oftalmol (Engl Ed). 2022 Nov;97(11):626-638. doi: 10.1016/j.oftale.2022.05.006. Epub 2022 Jul 23. Arch Soc Esp Oftalmol (Engl Ed). 2022. PMID: 35882576 Free article.
91 results